An elevated NLR identifies operable NSCLC patients with a poor prognostic outlook and an OS difference of almost 2 years compared to those with a normal score at diagnosis. Our study validates the clinical utility of the NLR in early-stage NSCLC.
No takes yet. Share an insight, caveat, or question.
Pinato et al. (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: